
Josh Schoeller, LexisNexis Risk Solutions
Advertisement
Articles by Josh Schoeller, LexisNexis Risk Solutions

Advertisement
Latest Updated Articles
The next generation of MDMOctober 29th 2014
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How the US Section 301 Probe Targets Germany's Drug Pricing
2
Philip Sclafani: Will PBM Reform Actually Lower Net Drug Costs?
3
Report: GLP-1s, Oncology to Drive Drug Spending Surge in 2027
4
How GLP-1 Growth and Specialty Drugs Are Driving Cost Pressure
5